How should the dose of Augmentin (amoxicillin/clavulanate) be adjusted in patients with impaired renal function based on Glomerular Filtration Rate (GFR)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Augmentin Dose Adjustment Based on GFR

For patients with GFR ≥30 mL/min, use standard Augmentin dosing without adjustment; for GFR 10-30 mL/min, reduce frequency to every 12 hours (500/125 mg or 250/125 mg depending on infection severity); for GFR <10 mL/min or hemodialysis patients, reduce to every 24 hours with an additional dose during and after dialysis. 1

Specific Dosing Recommendations by GFR Category

Normal to Mild Renal Impairment (GFR ≥30 mL/min)

  • No dose adjustment required 1
  • Standard adult dosing applies: 875/125 mg twice daily or 500/125 mg three times daily depending on infection severity 1
  • The 875/125 mg formulation should not be used if GFR falls below 30 mL/min 1

Moderate Renal Impairment (GFR 10-30 mL/min)

  • Reduce dosing frequency to every 12 hours 1
  • Choose between:
    • 500/125 mg every 12 hours for more severe infections 1
    • 250/125 mg every 12 hours for less severe infections 1
  • Both amoxicillin and clavulanic acid are renally excreted, necessitating this adjustment to prevent drug accumulation 2

Severe Renal Impairment (GFR <10 mL/min)

  • Reduce dosing frequency to every 24 hours 1
  • Choose between:
    • 500/125 mg every 24 hours for more severe infections 1
    • 250/125 mg every 24 hours for less severe infections 1

Hemodialysis Patients

  • Administer 500/125 mg or 250/125 mg every 24 hours based on infection severity 1
  • Critical timing consideration: Give an additional dose both during and at the end of dialysis, as hemodialysis removes both amoxicillin and clavulanic acid from circulation 1
  • This supplemental dosing compensates for drug removal during the dialysis session 2

Important Clinical Considerations

Formulation Restrictions

  • The 875/125 mg tablet is contraindicated when GFR <30 mL/min 1
  • Different Augmentin formulations contain varying amounts of clavulanic acid and are not interchangeable: two 250/125 mg tablets do not equal one 500/125 mg tablet 1

Monitoring Requirements

  • GFR estimation should guide initial dosing decisions 2, 3
  • In elderly patients (>65 years), renal function may be overestimated by serum creatinine alone, increasing risk of drug accumulation 3, 4
  • Patients with advanced chronic kidney disease require careful monitoring as GFR-estimating equations become less accurate at lower GFR values 4

Risk of Inappropriate Dosing

  • Failure to adjust doses in renal impairment leads to excessive drug accumulation and increased toxicity risk 2
  • In geriatric patients with reduced renal function, approximately 52% of medications require dosage adjustment, with antibiotics being among the most frequently used drugs needing modification 3
  • Routine assessment and reporting of estimated GFR is essential for appropriate antibiotic dosing in patients with chronic kidney disease 3, 5

References

Research

Pharmacokinetics and dosage adjustment in patients with renal dysfunction.

European journal of clinical pharmacology, 2009

Research

Glomerular filtration rate-estimating equations for patients with advanced chronic kidney disease.

Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 2013

Research

Estimating renal function for drug dosing decisions.

The Clinical biochemist. Reviews, 2011

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.